Literature DB >> 19939694

Superior vena cava resection in thoracic malignancies: does prosthetic replacement pose a higher risk?

Francesco Leo1, Roberto Bellini, Barbara Conti, Vincenzo Delledonne, Luca Tavecchio, Ugo Pastorino.   

Abstract

BACKGROUND: After superior vena cava (SVC) resection, the need for reconstruction varies among tangential resection, pericardial patch repair and prosthetic replacement. Patients undergoing complete prosthetic replacement often require a different surgical approach, intra-operative SVC cross-clamping and anticoagulation when polytetrafluoroethylene (PTFE) prosthesis is used. This study tested the hypothesis that PTFE replacement may interfere with perioperative outcome.
MATERIALS AND METHODS: Clinical records from a series of 72 consecutive SVC resections performed between 1998 and 2008 were reviewed. Complications were classed into five categories: surgical, respiratory, cardiac, SVC system thrombosis and nerve damage. Each category of postoperative complications was considered as an outcome variable in a univariate analysis testing 12 covariates as risk factors. Covariates considered clinically relevant or statistically significant were included in the multivariate model.
RESULTS: During the considered period, 28 patients underwent total SVC resection with PTFE prosthetic replacement and 44 patients underwent SVC repair by the use of direct running suture (nine patients), stapling (30 patients) or autologous pericardial patch (five patients). Two patients died postoperatively (2.8%). Major complications were mainly due to respiratory failure, which occurred in nine cases (acute respiratory failure in five cases, recurrent atelectasis in three cases, acute respiratory distress syndrome (ARDS) in one case). In terms of overall mortality and morbidity, univariate analysis did not confirm a detrimental effect of SVC replacement as compared with SVC repair, as major postoperative complications occurred in similar proportion in both groups (respectively, 6/28, 21.4% vs 7/44, 15.9%, p=0.54). No other risk factor was identified by univariate analysis.
CONCLUSIONS: Complete prosthetic replacement does not increase overall postoperative morbidity in patients undergoing SVC resection and can be safely performed when other reconstruction techniques preclude sufficient tumour-free resection margin or compromise adequate blood flow. Copyright (c) 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19939694     DOI: 10.1016/j.ejcts.2009.10.024

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  8 in total

1.  Reconstruction of mediastinal vessels for invasive thymoma: a retrospective analysis of 25 cases.

Authors:  Yifeng Sun; Chang Gu; Jianxin Shi; Wentao Fang; Qingquan Luo; Dingzhong Hu; Shijie Fu; Xufeng Pan; Yong Chen; Yu Yang; Haitang Yang; Heng Zhao; Haiquan Chen
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

2.  Prosthetic graft interposition of the brachiocephalic veins or superior vena cava combined with resection of malignant tumours: graft patency and risk factors for graft occlusion.

Authors:  Geun Dong Lee; Hyeong Ryul Kim; Se Hoon Choi; Yong-Hee Kim; Dong Kwan Kim; Seung-Il Park
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

3.  Patency of grafts after total resection and reconstruction of the superior vena cava for thoracic malignancy.

Authors:  Hiroaki Oizumi; Kenji Suzuki; Takamitsu Banno; Takeshi Matsunaga; Shiaki Oh; Kazuya Takamochi
Journal:  Surg Today       Date:  2016-06-14       Impact factor: 2.549

Review 4.  Surgery for malignant lesions of the chest which extensively involved the mediastinum, lung, and heart.

Authors:  Yugo Tanaka; Daisuke Hokka; Hiroyuki Ogawa; Nahoko Shimizu; Takeshi Inoue; Hiroshi Tanaka; Yutaka Okita; Yoshimasa Maniwa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-05-24

Review 5.  Is it safe to divide and ligate the left innominate vein in complex cardiothoracic surgeries?

Authors:  Arthur McPhee; Kasra Shaikhrezai; Geoffrey Berg
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-06-04

6.  Thoracoscopic thymectomy with partial superior vena cava resection for locally advanced thymomas.

Authors:  Ning Xu; Zhitao Gu; Chunyu Ji; Xuefei Zhang; Tangbing Chen; Wentao Fang
Journal:  J Thorac Dis       Date:  2019-02       Impact factor: 2.895

7.  Preliminary evaluation and discussion of the safety of left innominate vein resection.

Authors:  Hai-Qiang Wang; Feng Tian; Miao Wei; Lian-Hong Chen; Shao-Yi Cheng; Zheng Feng; Jun Ma; Tian-Yi Zhang; Yi-Ze Guo; Xun-Liang Yin; Zheng-Wei Zhao; Yong-An Zhou
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

8.  Superior vena cava resection and reconstruction in mediastinal tumors and benign diseases.

Authors:  Erkan Kaba; Berker Özkan; Mehmet Oğuzhan Özyurtkan; Kemal Ayalp; Alper Toker
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-01-09       Impact factor: 0.332

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.